These were filed by Roger last year, around the time (I think immediately preceding) the news about MPL v COVID.
Another of the patents that have been granted to Pitney is for the use of aminoacetonitrile compounts in the treatment of mTOR pathway related diseases - it's extremely broad and does mention in the discussion:
"The MPL/autophagy effect according to the present invention shows that MPL and similar AAD's is useful in treating diseases where autophagy is deficient, such as stroke, neurodegenerative diseases, al antitrypsin deficiencies, lysosomal storage disorders, cardiomyopathy, immune disorders and autoimmune disease, bacterial and viral infection, parasites, lipid disorders and even ageing."
It is likely that anyone else looking to use MPL to treat COVID would infringe PAA's IP - even if that 'someone' is the owner of the materials patent.
PHARMAUST ALL SET FOR ELY LILLY T/O, page-273
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.0¢ | $91.02K | 417.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2325 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 119713 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2325 | 0.215 |
7 | 63630 | 0.210 |
4 | 193228 | 0.205 |
9 | 159603 | 0.200 |
4 | 276128 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 119713 | 2 |
0.230 | 24215 | 3 |
0.235 | 50000 | 1 |
0.240 | 44200 | 1 |
0.245 | 55000 | 4 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
22.0¢ |
  |
Change
0.000 ( 5.72 %) |
|||
Open | High | Low | Volume | ||
23.0¢ | 23.0¢ | 21.0¢ | 271600 | ||
Last updated 15.42pm 06/05/2024 ? |
Featured News
PAA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online